BGBaşak Gökçe

Başak Gökçe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Başak Gökçe has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sulfonamide‐Based 2‐Amino‐1,3,4‐Oxadiazole Derivatives as Dual Cholinesterase and Carbonic Anhydrase Inhibitors: Design, Synthesis, Kinetic Characterization, Molecular Modeling, and ADMET Evaluation

    by Gülnur Arslan Karahan, Başak Gökçe, Muhammed Tilahun Muhammed, Emre Kadir Ayan, Azime Berna Özçelik

    In this study, 12 novel sulfonamide derivatives incorporating 2‐amino‐1,3,4‐oxadiazole and 1,3‐benzazol‐2(3 H )‐one scaffolds were synthesized and structurally characterized using 1 H NMR, 13 C NMR, and LC–MS analyses. Their inhibitory activities were evaluated against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), carbonic anhydrase I and II (CA I and CA II), and α‐glucosidase. Owing to their potent inhibitory profiles, enzyme kinetic studies were performed to determine inhibition constants ( Ki ) and inhibition mechanisms. The synthesized compounds exhibited potent nanomolar cholinesterase inhibition. Compound 5b was identified as the most active AChE inhibitor (IC 50 = 32.6 ± 2.6 nM; Kᵢ = 7.1 ± 0.6 nM), acting through a competitive inhibition mechanism, whereas compound 5g showed the strongest BChE inhibition (IC 50 = 34.6 ± 2.8 nM; Kᵢ = 8.4 ± 0.8 nM) with a mixed‐type inhibition profile. The derivatives also displayed significant carbonic anhydrase inhibition, with compound 6d emerging as the most potent inhibitor, particularly against CA II (IC 50 = 0.9 ± 0.06 μM; Kᵢ = 0.43 ± 0.037 μM), while exhibiting competitive inhibition and strong activity against both CA isoforms. In contrast, α‐glucosidase inhibition was generally weak, with compound 5d showing the highest activity (IC 50 = 250.5 ± 21.32 μM). Molecular docking studies revealed favorable binding interactions within the catalytic sites of cholinesterase and carbonic anhydrase enzymes, while 200 ns length molecular dynamics simulations confirmed the stability of representative protein–ligand complexes. In silico ADMET and drug‐likeness predictions using SwissADME and pkCSM indicated generally acceptable oral drug‐likeness. Compound 6c exhibited the most balanced predicted pharmacokinetic profile, whereas 6d , despite its excellent enzyme inhibition, showed potential limitations associated with higher polarity, limited predicted blood–brain barrier penetration, and predicted toxicity risks. Overall, these findings identify the synthesized sulfonamide derivatives as promising scaffolds for the further development of multifunctional cholinesterase and carbonic anhydrase inhibitors.

  • Inhibition and Molecular Recognition of Lactoperoxidase by Acetohydrazide‐Based Sulfonamide Derivatives

    by Başak Gökçe, Gülnur Arslan, Muhammed Tilahun Muhammed, Özlem Albayrak

    Lactoperoxidase (LPO) is a heme‐containing enzyme widely distributed in mammalian secretions, contributing to host defense through the generation of antimicrobial oxidants. Unintended inhibition of LPO by therapeutic agents may impair mucosal immunity, making the investigation of potential inhibitors clinically relevant. In this study, the inhibitory effects of 11 acetohydrazide‐based sulfonamide derivatives on bovine milk LPO were investigated using combined biochemical and computational approaches. The compounds exhibited diverse inhibition profiles, with IC 50 values ranging from 2.32 ± 0.14 to 13.4 ± 2.05 μM. The corresponding Kᵢ values were determined in the low micromolar range, varying from 1.25 ± 0.05 to 7.53 ± 0.03 μM. Among them, 4b‐2 (3‐pyridyl) and 4a‐5 (2‐naphthyl) derivatives were identified as the most potent inhibitors, acting through a competitive inhibition mechanism with low micromolar Kᵢ values. The binding mechanisms of relatively active compounds in the enzymatic assay were explored through molecular modeling. The docking study disclosed that compounds 4a‐5 and 4b‐2 would show higher binding potential to the LPO structure. The two compounds formed stable complexes with the enzyme structure according to the molecular dynamics (MD) simulation study. These interactions were mainly governed by hydrogen bonding and π–π stacking interactions involving key residues in the heme‐containing active site, supporting a competitive binding mode consistent with the kinetic data. Overall, the combined biochemical and computational findings suggest that acetohydrazide‐based sulfonamides represent promising scaffolds for the development of potent and selective LPO inhibitors and provide new insights into the molecular recognition patterns governing their interaction with the LPO active site.

  • Yeni Nesil Kozmetik Peptid Argireline (Asetil heksapeptid-8) Molekülünün in vitro Anti-Tirozinaz, Anti-Kollajenaz, Anti-Elastaz ve Anti Hyalüronidaz Etkilerinin Araştırılması

    by Basak Gokce

    Bu çalışma, yeni nesil kozmetik peptid argireline molekülünün cilt yaşlanma süreçlerinde yer alan bazı enzim aktiviteleri üzerindeki değişimini değerlendirmek için tasarlanmıştır. Tirozinaz, kolejenaz, elastaz ve hiyalüronidaz enzimleri cilt yaşlanmasında, doğrudan ve terapötik etkileri nedeniyle dikkat çeken enzimlerdir. Yüksek elastaz inhibisyonu kırışıklık önleyici, tirozinaz inhibisyonu beyazlatma etkili, kolejenaz inhibisyonu esneklik ve hyalüronidaz inhibisyonu anti-inflamasyon etkisi göstermektedir. Bu nedenle, son dönemlerde kozmetikte trend olarak kullanılan argireline molekülünün, etkinliği çalışılmıştır. Test edilen genel aktiviteler göz önüne alındığında, argireline bileşiğinin umut verici yaşlanma karşıtı bileşik olduğu değerlendirilmiştir.


  • Evaluation of in vitro effect, molecular docking, and molecular dynamics simulations of some dihydropyridine‐class calcium channel blockers on human serum paraoxonase 1 (hPON1) enzyme activity

    by Başak Gökçe, Muhammed Tilahun Muhammed

    Paraoxonase 1 (PON1) was purified 148.80‐fold in 37.92% yield by hydrophobic interaction chromatography technique. The purity of PON1 was checked by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS‐PAGE) with a single band of 43 kDa. The in vitro effects of nine different calcium channel blockers on PON1 activity were evaluated. All drugs strongly decreased PON1 activity, and IC50 levels were between 13.987 ± 0.59 and 238.104 ± 2.14 μM, Ki values between 8.58 ± 0.36 and 111 ± 1.27 μM. The drugs with the strongest inhibitory effect were nisoldipine with 13.987 ± 0.59 μM and nicardipine with 20.158 ± 0.43 μM. The mechanism of action for the inhibition of the enzyme by nisoldipine and nicardipine was investigated through molecular docking. The stability of enzyme–ligand complexes obtained from the docking was explored through molecular dynamics simulation. The binding affinity of the ligands toward the enzyme was also investigated through MMPBSA (molecular mechanics Poisson–Boltzmann surface area method). The computational analysis demonstrated these compounds could inhibit the enzyme. Nisoldipine had the strongest binding, and its complex was the most stable one. Furthermore, nicardipine was found to have the highest affinity toward the enzyme.


  • Association of human serum paraoxonase‐1 with some respiratory drugs

    by Başak Gökçe, Nurhan Sarıoğlu, Nahit Gençer, Oktay Arslan

    In this study, we investigated the effects of certain respiratory drugs, which are mainly used on human serum paraoxonase‐1 (hPON1; EC 3.1.8.1). hPON1 was purified from human serum, with 354.91 fold and 45% yield by using two simple step procedures including, first, ammonium sulfate precipitation, then, Sepharose‐4B‐l‐tyrosine‐1‐naphthylamine hydrophobic interaction chromatography. SDS‐polyacrylamide gel electrophoresis showed a single protein band belonging to hPON1 with 43 kDa. All the pharmaceutical compounds inhibited the PON1 enzyme highly at the micromolar level. The obtained IC50 values for nine different pharmaceutics ranged from 0.219 μM (salbutamol sulfate) to 67.205 μM (montelukast sodium). So, all drugs could be considered as potent hPON1 inhibitors. Ki values and inhibition types were determined by Lineweaver‐Burk graphs. While varenicline tartrate and moxifloxacin hydrochloride inhibited the enzyme in a noncompetitive manner, others inhibited it in a mixed manner.


  • Open Access

    Bazı antrakinonların insan paraoksonaz 1 (hPON1) üzerine etkilerinin incelenmesi

    by Başak GÖKÇE

    En tr The in vitro effects of the some dihydroxyanthraquinone derivates, anthrorufin, xanthopurpurin, chrysazin and chrysaphanol which are commonly used as anticancer antibiotics, on the activity of purified serum paraoxonase 1 (PON1) (EC 3.1.8.1.) were investigated. Paraoxonase 1 was purified from human blood serum 355,12 fold with 55 % yield with use of ammonium sulphate precipitation and Sepharose-4B-L-tyrozine-1-napthylamine HIC (hydrophobic interaction chromatography) coloumn in return. Sodium Dodecyl Sulphate -polyacrylamide gel electrophoresis (SDS-PAGE) analysis of purified enzyme showed a single band belong to human serum PON1, 43 kDa. The four anthraquinones inhibited PON activity strongly, with IC50 values for anthrorufin, xanthopurpurin, chrysazin and chrysaphanol of 73, 72.25, 75.19 and 105.53 M respectively. Ki constants were determined 34.64, 39.51, 39.73 and 63.59 M, respectively. All anthraquinones showed inhibition in competitive manner. Antikanser antibiyotikler olarak yaygın kullanılan bazı dihidroksiantrakinon türevlerinin (antrorufin, ksantopurpirin, krisazin ve krizofanol) saflaştırılmış serum paraoksonaz 1 (PON1) aktivitesi üzerine (EC 3.1.8.1) in vitro etkileri araştırıldı. Paraoksonaz 1, insan kan serumundan 355,12 kat, % 55 verimle, amonyum sülfat çöktürmesi ve Sepharose 4B-L-tirozin-1-naftilamin hidrofobik etkileşim kromatografisi kullanılarak saflaştırılmıştır. Saflaştırılmış enzimin Sodyum Dodesil Sülfat-poliakrilamid jel elektroforezi (SDS-PAGE), insan serum PON1’e ait 43 kDa'lık tek bant gösterdi. Dört antrakinon bileşiği, PON1 aktivitesini, sırasıyla antrorufin, ksantopurpirin, krisazin ve krizofanol için 73, 72.25, 75.19 ve 105.53 M değerleri ile güçlü bir şekilde inhibe etmiştir. Ki sabitleri sırasıyla 34.64, 39.51, 39.73 ve 63.59 M olarak bulunmuştur. Tüm antrakinonlar yarışmalı bir şekilde inhibisyon göstermiştir.


  • Synthesis of carbazole bearing pyridopyrimidine‐substituted sulfonamide derivatives and studies their carbonic anhydrase enzyme activity

    by Arleta Rifati‐Nixha, Mustafa Arslan, Nahit Gençer, Kübra Çıkrıkıçı, Başak Gökçe, Oktay Arslan

    The synthesis of carbazole containing pyridopyrimidine‐substituted sulfonamide derivatives (3a‐i) and their inhibitory effects on human carbonic anhydrase (hCA) I and II were studied. Spectral data and elemental analysis confirmed the structures of the compounds synthesized. The results show that all the synthesized compounds inhibited the CA I and II activities. Among them, 3a was found to be the most active ( K i: 14 µM) for hCA I and 3f ( K i: 126 µM) for hCA II.


  • Open Access

    Review of Chromatography Methods for Purfication of Paraoxonase Enzyme

    by Basak Gokce

    Human serum paraoxonase1 (hPON1) is a calcium dependant enzyme which has an important physiological role in organism with detoxification, antioxidant and also antiatherogenic properties. PON1 is mostly synthesized from the liver than secreted in serum with located on HDL. In order to better understand the molecular mechanism of paraoxonase 1, researchers have been increasingly interested in the development of various methods for obtaining the enzyme in pure form over the last decades. In this paper, it was reviewed several different purification and characterization methods of multifunctional enzyme paraoxonase 1 (EC 3.1.8.1). Keywords: Paraoxonase1; Chromatography Methods; Enzyme Purification and Characterization DOI: 10.17350/HJSE19030000102 Full Text: